scispace - formally typeset
M

Martina Galatola

Researcher at University of Naples Federico II

Publications -  21
Citations -  420

Martina Galatola is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Disease & Internal medicine. The author has an hindex of 11, co-authored 18 publications receiving 308 citations.

Papers
More filters
Journal ArticleDOI

Potential celiac children: 9-year follow-up on a gluten-containing diet

TL;DR: A sizeable proportion of asymptomatic potential celiac patients showed fluctuation or negativization of antibody production, and many of these, with persistently positive anti-TG2, did not develop mucosal damage after 9 years of follow-up.
Journal ArticleDOI

Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.

TL;DR: In a long-term study of 280 children with suspected celiac disease (based on anti-TG2 and anti-EMA on gluten-containing diets), the cumulative incidence of progression to villous atrophy was 43% over a 12-year period.
Journal ArticleDOI

Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.

TL;DR: It is suggested that β-catenin and TNFRI protein expression in peripheral blood cells could represent molecular markers of sub-clinical disease in apparently healthy relatives of patients with early-onset UC.
Journal ArticleDOI

Gene expression profile of peripheral blood monocytes: a step towards the molecular diagnosis of celiac disease?

TL;DR: The expression of CD-associated genes in small bowel biopsies of patients and controls is analysed to explore the multivariant pathway of the expression profile of CD patients and contribute to the understanding of the complex interactions among CD- associated genes.
Journal ArticleDOI

A Phospholipid Profile at 4 Months Predicts the Onset of Celiac Disease in at-Risk Infants

TL;DR: A specifc phopholipid profile is unveiled, able to discriminate infants who eventually develop celiac disease years before antibodies or clinical symptoms ensue, and is suggested that the state of the host is a main factor for the abnormal immune response to gluten.